MolNFT v1 · #63618 · protein
Crystal structure of an uncharacterized cystatin fold protein (SARO_2299) from novosphingobium aromaticivorans dsm at 1.90 a resolution
3FF2 · Uncharacterized cystatin fold protein (YP_497570.1) from…: “Crystal structure of an uncharacterized cystatin fold protein (SARO_2299) from novosphingobium…”. X-ray diffraction, 1 pocket (best druggability 0.54). MolNFT v1 #63618 on…
- PDB
- 3FF2
- Type
- protein
- Length
- 117 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Uncharacterized cystatin fold protein (YP_497570.1) from NTF2 superfamily
- UniProt
- Q2G5Y7
- Pockets
- 1 · best druggability 0.54
Structure
x-ray diffraction · 1 distinct chain · 28% helix, 42% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Uncharacterized cystatin fold protein (YP_497570.1) from NTF2 superfamily | protein | 117 | 28% helix, 42% strand | Q2G5Y7 |
Ligands and binding sites
- ACT · Acetate ion · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 104 | 0.54 | 0.83 | 23 | ACT |
Modifications
Observed in the structure: 4 modified (engineered).
Compared structures
- 3FF2 · Crystal structure of an uncharacterized cystatin fold protein (saro_2299) from… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q2G5Y7
- Elsewhere: RCSB PDB 3FF2 · PDBe 3FF2 · UniProt Q2G5Y7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.